A Pituitary Society update to acromegaly management guidelines
Year: 2020
Type: review
Abstract: Guidelines and consensus statements ensure that physicians managing acromegaly patients have access to current information on evidence-based treatments to optimize outcomes. Given significant novel recent advances in understanding acromegaly natural history and individualized therapies, the Pituitary Society invited acromegaly experts to critically review the current literature in the context of Endocrine Society guidelines and Acromegaly Consensus Group statements. This update focuses on how recent key advances affect treatment decision-making and outcomes, and also highlights the likely role of recently FDA-approved therapies as well as novel combination therapies within the treatment armamentarium.
Source: Pituitary
Institutions: Oregon Health & Science University, Harvard University, Massachusetts General Hospital, Columbia University, Universidade Federal do Rio de Janeiro, Hospital Universitário Clementino Fraga Filho, Vita-Salute San Raffaele University, IRCCS Ospedale San Raffaele, Stanford Medicine, Stanford University, Northwestern University, Baylor College of Medicine, Charité – Universitätsmedizin Berlin, Erasmus MC, Cedars-Sinai Medical Center
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,860
OpenAlex ID: W3093391611